Neurocrine Biosciences
NBIX
#1542
Rank
โ‚ฌ10.01 B
Marketcap
100,40ย โ‚ฌ
Share price
-0.07%
Change (1 day)
-22.63%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): โ‚ฌ0.47 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are โ‚ฌ2.35 Billion. , an increase over its 2023 earnings that were of โ‚ฌ0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ0.47 B64.57%
2023 โ‚ฌ0.28 B41.13%
2022 โ‚ฌ0.20 B73.74%
2021 โ‚ฌ0.11 B-8.82%
2020 โ‚ฌ0.12 B77.78%
2019 โ‚ฌ72.28 M49.83%
2018 โ‚ฌ48.24 M-142.57%
2017 -โ‚ฌ0.12 Billion-14.73%
2016 -โ‚ฌ0.14 Billion53.15%
2015 -โ‚ฌ86.78 Million46.25%
2014 -โ‚ฌ59.34 Million29.66%
2013 -โ‚ฌ45.77 Million-3530.8%
2012 โ‚ฌ1.33 M-95.73%
2011 โ‚ฌ31.24 M
2009 -โ‚ฌ43.93 Million-45.38%
2008 -โ‚ฌ80.42 Million-58.87%
2007 -โ‚ฌ0.2 Billion87.3%
2006 -โ‚ฌ0.11 Billion351.97%
2005 -โ‚ฌ23.1 Million-52.09%
2004 -โ‚ฌ48.22 Million-10.98%
2003 -โ‚ฌ54.16 Million
2001 -โ‚ฌ40.43 Million
1999 -โ‚ฌ18.24 Million108.32%
1998 -โ‚ฌ8.76 Million
1996 โ‚ฌ2.67 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ17.7 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.43 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚ฌ24.82 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.68 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.42 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.39 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.92 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ38.48 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA